Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer
specificEstrogen receptor-positive breast adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes.
16
Centers
16
Active Trials
—
Cancer Funding
Top Centers for Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer(16)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 53.1 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 53.1 |
| 3 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 53.1 |
| 4 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 53.1 |
| 5 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program | 53.1 |
| 6 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 53.1 |
| 7 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 53.1 |
| 8 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 53.1 |
| 9 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 53.1 |
| 10 | University of Illinois Cancer CenterChicago, IL Active Research Program | 53.1 |
| 11 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 53.1 |
| 12 | Boston University Cancer CenterBoston, MA Active Research Program | 53.1 |
| 13 | Active Research Program | 53.1 |
| 14 | Cancer Center at IllinoisUrbana, IL Active Research Program | 53.1 |
| 15 | Stony Brook Cancer CenterStony Brook, NY Active Research Program | 53.1 |
| 16 | University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program | 53.1 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →